Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,225 public trials 3,228 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

NCT04699188

Conditions
Bronchial Neoplasms, Cancer of Lung, Cancer of the Lung, +29 more
Locations
  • Emory University School of Medicine-Winship Cancer Institute Atlanta, Georgia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation

NCT05194995

Conditions
Advanced Colorectal Cancer, Appendiceal Cancer, Appendiceal Neoplasms, +11 more
Locations
  • Research site31 Beijing, Beijing Municipality, China
  • Research site01 Beijing, Beijing Municipality, China
  • Research site02 Beijing, Beijing Municipality, China
  • Research site12 Beijing, Beijing Municipality, China
View all 17 locations
View Trial Details
Active, Not Recruiting

Cola Ingestion for Esophageal Bolus Impaction

NCT06652620

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations
  • Fudan University Shanghai Cancer Center Xiamen Hospital Xiamen, Fujian, China
  • The Northern Jiangsu People's Hospital Yangzhou, Jiangsu, China
  • First People's Hospital Jingdezhen, Jiangxi, China
  • Fudan University Shanghai Cancer Center Shanghai, China
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

NCT06256328

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Matsuyama Red Cross Hospital Matsuyama, Ehime, Japan
  • NHO Shikoku Cancer Center Matsuyama, Ehime, Japan
View all 63 locations
View Trial Details
Active, Not Recruiting

Avatrombopag vs. Placebo for CIT in GI Malignancies

NCT05772546

Conditions
Chemotherapy-Induced Thrombocytopenia, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Oregon Health and Science University Hospital Portland, Oregon, United States
  • University of Washington Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details

Related conditions